D-0077-2027 Class II Ongoing

Recalled by MACLEODS PHARMA USA, INC — Princeton, NJ

FDA drug recall D-0077-2027 was initiated by MACLEODS PHARMA USA, INC on Oct 7, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications. The recall status is ongoing. Affected quantity: 3528 30-count and 216 90-count bottles.

Recall details

Product Type
Drugs
Report Date
Nov 4, 2026
Initiation Date
Oct 7, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3528 30-count and 216 90-count bottles

Product description

Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Tablets 40 mg/10 mg/12.5mg, packaged as a) 30-count bottle, NDC 33342-246-07; b) 90-count bottle, NDC 33342-246-10; Rx Only, Manufactured for : Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured by: Macleods Pharmaceuticals Ltd, Daman, 396210, India

Reason for recall

Failed Dissolution Specifications.

Distribution pattern

Nationwide in the USA

Code information

Lot #: a) 12251163A, Exp 05-31-2027; b) 12251163B, Exp 05-31-2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0077-2027
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0077-2027. Report a data issue: hello@regdatalab.com.